Document is current
Any future updates will be listed below
-
Authors
Schober, Kilian http://orcid.org/0000-0001-9323-9472
Müller, Thomas R. http://orcid.org/0000-0001-5331-5522
Gökmen, Füsun
Grassmann, Simon
Effenberger, Manuel
Poltorak, Mateusz
Stemberger, Christian
Schumann, Kathrin
Roth, Theodore L.
Marson, Alexander
Busch, Dirk H. http://orcid.org/0000-0001-8713-093X
- License Information
-
More Information
Article History
Received: 30 July 2018
Accepted: 26 April 2019
First Online: 10 June 2019
Competing interests
: D.H.B. is co-founder of STAGE Cell Therapeutics GmbH (now Juno Therapeutics/Celgene) and T Cell Factory B.V. (now Kite/Gilead). D.H.B. has a consulting contract with and receives sponsored research support from Juno Therapeutics/Celgene. M.P. and C.S. are employees of Juno Therapeutics/Celgene. A.M. is on the scientific advisory board of PACT Pharma, serves as an advisor to Sonoma Biotherapeutics and previously served as an advisor to Juno Therapeutics and is a co-founder of Spotlight Therapeutics and Arsenal Biosciences. T.L.R. is a co-founder of Arsenal Biosciences. The Marson lab has received sponsored research support from Epinomics, Juno Therapeutics and Sanofi, and a gift from Gilead. A.M. and T.L.R. have previously filed related patent applications.
